Skip to content
★ Sign in to follow
BA

Blake Aftab

Directeur Scientifique
Total declarations
21
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€562k

Latest filing published 27 Jan 2026 for Adicet Bio, Inc., €3,841.

Filing timeline

BuySale
Blake Aftab

Insider track record

Disclosed buys
0
Disclosed sells
6

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Blake Aftab: trading record in brief

Blake Aftab, listed as senior executive, appears in our data through filings on Adicet Bio, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 12 October 2021 to 24 January 2026, the count stands at 21 filings.

On the market, this insider has only sold: 6 sales, €562k in total. Besides market trades, the filings include 14 share grants and 1 option exercise.

Most recently, on 27 January 2026, the filings show a share grant worth €3,841 in Adicet Bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Blake Aftab

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total
  • ◆
    Chief Scientific OfficerExecutivesAdicet Bio, Inc.
    4,515 USD25SEC
    535 shares@ US$8.440.7% of flowCommon StockSEC:0001193125-26-024755:0
  • ◆
    Chief Scientific OfficerExecutivesAdicet Bio, Inc.
    5,780 USD25SEC
    6,270 shares@ US$0.92180.9% of flowCommon StockSEC:0000950170-25-009838:0
  • ◆
    Chief Scientific OfficerExecutivesAdicet Bio, Inc.
    8,556 USD25SEC
    3,565 shares@ US$2.401.3% of flowCommon StockSEC:0000950170-24-008050:0
  • ◆
    Chief Scientific OfficerExecutivesAdicet Bio, Inc.
    10,710 USD25SEC
    7,933 shares@ US$1.351.7% of flowCommon StockSEC:0001209191-23-052845:0
  • ◆
    Chief Scientific OfficerExecutivesAdicet Bio, Inc.
    0SEC
    26,100 shares0Common StockSEC:0001209191-23-005040:0
  • ▼
    Chief Scientific OfficerExecutivesAdicet Bio, Inc.
    146,307 USD39SEC
    6,967 shares@ US$21.0024.8% of flowCommon StockSEC:0001209191-22-057005:0
  • ▼
    Chief Scientific OfficerExecutivesAdicet Bio, Inc.
    131,250 USD39SEC
    8,067 shares@ US$16.2722.8% of flowCommon StockSEC:0001209191-22-054261:0
  • ◇
    Chief Scientific OfficerExecutivesAdicet Bio, Inc.
    25,003 USD25SEC
    3,388 shares@ US$7.384.4% of flowCommon StockSEC:0001209191-22-053659:0
  • ◆
    Chief Scientific OfficerExecutivesAdicet Bio, Inc.
    0SEC
    16,000 shares0Common StockSEC:0001209191-22-044903:0
  • ▼
    Chief Scientific OfficerExecutivesAdicet Bio, Inc.
    125,424 USD27SEC
    6,968 shares@ US$18.0021.0% of flowCommon StockSEC:0001209191-22-044646:0
  • ▼
    Chief Scientific OfficerExecutivesAdicet Bio, Inc.
    115,948 USD27SEC
    6,968 shares@ US$16.6419.2% of flowCommon StockSEC:0001209191-22-044182:0
  • ▼
    Chief Scientific OfficerExecutivesAdicet Bio, Inc.
    19,764 USD25SEC
    1,363 shares@ US$14.503.3% of flowCommon StockSEC:0001209191-22-041499:0
  • ◆
    Chief Scientific OfficerExecutivesAdicet Bio, Inc.
    0SEC
    16,000 shares0Common StockSEC:0001209191-22-010485:0
  • ◆
    Chief Scientific OfficerExecutivesAdicet Bio, Inc.
    0SEC
    16,000 shares0Common StockSEC:0001209191-22-006136:0
  • ◆
    Chief Scientific OfficerExecutivesAdicet Bio, Inc.
    0SEC
    80,000 shares0Common StockSEC:0001209191-21-060360:0

15 of 15 declarations